Cyclophosphamide for Systemic Sclerosis-Related Interstitial Lung Disease: A Comparison of Scleroderma Lung Studies I and II

OBJECTIVES: To compare safety and efficacy outcomes between the cyclophosphamide (CYC) arms of Scleroderma Lung Study (SLS) I and II. METHODS: Participants enrolled in the CYC arms of SLS I (N=79) and II (N=73) were included. SLS I and II randomized participants to oral CYC for 1 year and followed p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Rheumatol
Main Authors: Volkmann, Elizabeth R., Tashkin, Donald P., Sim, Myung, Li, Ning, Khanna, Dinesh, Roth, Michael D., Clements, Philip J., Hoffmann-Vold, Anna-Maria, Furst, Daniel E., Kim, Grace, Goldin, Jonathan, Elashoff, Robert M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6697251/
https://ncbi.nlm.nih.gov/pubmed/30770517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.180441
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados